Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices 17299 

subscale (C08) for one program that 

aims to improve mothers’ belief in their 

parenting skills. 

• Added items about confidence in 

future financial situations (C09a-C09b) 

for one program that aims to increase 

youths’ belief in their ability to become 

self-sufficient. 

• Added a question to ask if 

participants are covered by health 

insurance (C10b). 

• Added the Center for Epidemiologic 

Studies Depression Scale Revised 

(CESD–R) (C22a) for use by a program 

that serves mothers with symptoms of 

depression. For this program, this more 

in-depth depression scale will be used 

instead of the shorter K–6 Distress Scale 

(C22). 

• Added questions about whether the 

respondent is currently under courtordered supervision (C38), whether any 

convictions were for felonies (C42), and 

if any of the reported incarcerations 

were for violating the terms of courtordered supervision (C44) for a program 

that serves adults with criminal justice 

system involvement. 

• Removed some items asking 

program group study participants about 

their satisfaction with the program. 

We currently have OMB approval to 

provide a $40 gift card for follow-up 

survey completion. Based on new 

evidence, we propose to increase the 

first follow-up survey token of 

appreciation from $40 to $50 and to add 

a $5 prepaid gift card for the first 

follow-up survey sent with the advance 

letter. We would assess the effectiveness 

of the prepaid gift card using an 

experiment. If the experiment shows 

that prepaid tokens of appreciation are 

effective at increasing response rates or 

decreasing the treatment-control 

response rate differential, we will 

propose using it for remaining sample 

members for the first follow-up survey. 

Second Follow-Up Survey (Instrument 

4) 

We propose changes to the second 

follow-up survey to match the changes 

proposed for the first follow-up survey. 

We propose introducing a $5 prepaid 

token of appreciation if the experiment 

for the first follow-up survey 

demonstrates it is effective. We do not 

propose changes to the previously 

approved $50 postpaid gift card for the 

second follow-up survey. 

Respondents: Individuals enrolled in 

the NextGen Project. 

Annual Burden Estimates 

The annual burden estimates for the 

instruments we are requesting to revise 

are presented below. All currently 

approved materials under OMB # 0970– 

0545 and the associated burden can be 

found at: https://www.reginfo.gov/ 

public/do/PRAViewICR?ref_

nbr=202012-0970-003. 

Instrument 

Total 

number of 

respondents 

Annual 

number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Annual 

burden hours 

PHASE 2 

First follow-up survey—participants ..................................... 8,000 2,667 1 0.83 2,214 

Second follow-up survey—participants ................................ 8,000 2,667 1 0.83 2,214 

Total Annual Burden Hours, Phase 2: 

4,428. 

Authority: Section 413 of the Social 

Security Act, as amended by the FY 

2017 Consolidated Appropriations Act, 

2017 (Pub. L. 115–31). 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–06403 Filed 3–25–22; 8:45 am] 

BILLING CODE 4184–09–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Measuring Human Trafficking 

Prevalence in Construction: A Field 

Test of Multiple Estimation Methods 

(New Collection) 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF) is 

proposing a new data collection activity 

for Measuring Human Trafficking 

Prevalence in Construction: A Field Test 

of Multiple Estimation Methods. This 

study will examine the labor trafficking 

and other labor exploitation experiences 

among individuals who work in 

construction. The goal of this study is to 

advance knowledge of promising 

methods for estimating human 

trafficking prevalence by field-testing 

two methods of prevalence estimation 

within the construction industry in 

Houston, Texas. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The purpose of the 

proposed data collection activity is to 

estimate the prevalence of labor 

trafficking among construction workers 

in one location using two different 

sampling and estimation strategies. The 

proposed information collection activity 

is a one-time survey with up to 4,200 

adults who worked in the construction 

industry in the selected geographic 

location in the 24 months prior to data 

collection. The construction worker 

survey will be offered in English and 

Spanish to workers identified through 

the following two sampling strategies: 

(1) Probability sample (i.e., time 

location sample), and (2) a network 

sample. The survey instrument used for 

individuals recruited through the two 

different sampling strategies will be 

primarily the same and includes 

questions focused on the individuals’ 

experiences with labor exploitation and 

trafficking; employment histories, 

including work after a natural disaster; 

social networks; and demographic data. 

Respondents: English- and Spanishspeaking individuals who have worked 

in construction in Houston, Texas, in 

the 2 years prior to data collection will 

be invited to complete a survey. 


jspears on DSK121TN23PROD with NOTICES1
17300 Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices 

ANNUAL BURDEN ESTIMATES

Instrument 

Number of 

respondents 

(total over request period) 

Number of 

responses per 

respondent 

(total over request period) 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Total burden 

(in hours) 

Annual burden 

(in hours) 

Construction Worker Survey .................... 4,200 1 1 0.5 2,100 1,050 

Estimated Total Annual Burden 

Hours: 1,050. 

Authority: Section 105(d)(2) of the 

Trafficking Victims Protection Act of 

2000 (Pub. L. 106–386) [22 U.S.C. 7103]. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–06415 Filed 3–25–22; 8:45 am] 

BILLING CODE 4184–47–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0709] 

Prescription Drug User Fee Rates for 

Fiscal Year 2022; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice entitled ‘‘Prescription Drug User 

Fee Rates for Fiscal Year 2022’’ that 

appeared in the Federal Register of 

August 16, 2021. The document 

announced the Fiscal Year 2022 fee 

rates for the Prescription Drug User Fee 

Act. The document published with 

errors. The errors did not have an 

impact on the previously published user 

fee rates but are corrected in this 

document for clarity. 

FOR FURTHER INFORMATION CONTACT: 

Misbah Tareen, Office of Financial 

Management, Food and Drug 

Administration, 4041 Powder Mill Rd., 

Rm. 61077A, Beltsville, MD 20705– 

4304, 301–796–3997. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of August 16, 2021 (86 

FR 45732), appearing on page 45736 in 

FR Doc. 2021–17505, the following 

corrections are made: 

1. In the second column, in the last 

sentence of the third paragraph under 

‘‘D. FY 2022 Statutory Fee Revenue 

Adjustments for Operating Reserve’’, 

‘‘both user fee funds available for 

obligation $126,873,636 and funds that 

are considered unavailable due to a lack 

of appropriations $98,850,995’’ is 

corrected to read ‘‘user fee funds 

considered unavailable due to a lack of 

appropriations $78,850,995, additional 

fee funds that are available for 

obligation but set aside for future year 

refunds as a matter of prudent 

operations $20,000,000, and carryover 

net of unavailable funds and the setaside $126,873,636.’’ 

2. The fourth footnote is corrected by 

removing the text and replacing it with: 

‘‘In recent PDUFA Annual Financial 

Reports, the category ‘‘unavailable for 

use’’ has been used to refer both to (1) 

fee funds that are considered 

unappropriated and (2) appropriated fee 

funds the Agency has maintained to 

provide for any refunds. FDA intends to 

discontinue use of the category 

‘‘unavailable for use’’ in forthcoming 

reports to better reflect the difference 

between these line items and improve 

the clarity of its reporting. Although 

certain amounts have been maintained 

for future refunds as a matter of prudent 

operations, these amounts are 

considered appropriated and are 

available for obligation.’’ 

3. In the second column, in the fifth 

paragraph under ‘‘D. FY 2022, Statutory 

Fee Revenue Adjustments for Operating 

Reserve’’, sentences 4 through 7 are 

corrected by removing the text and 

replacing it with ‘‘FDA has decided to 

make an available operating reserve 

adjustment that is intended to increase 

the amount of available funds to 

approximately 8 weeks by the end of FY 

2022, representing the low end of the 8- 

to 10-week range while mitigating the 

impact on fee amounts. FDA estimates 

the cost of operations per week is 

$22,144,672. Before the operating 

adjustment, the estimated end of year 

FY 2022 available operating reserve is 

$145,677,240, which equates to about 

61⁄2 weeks of available operating 

reserves. Adding the FY 2022 operating 

reserve adjustment of $39,402,923 to 

this amount is expected to provide 

approximately 8 weeks of available 

operating reserve, or $185,080,162 

(including $20,000,000 in available fee 

funds maintained for any future 

refunds), and a total carryover of 

operating reserves (including 

unavailable funds) of $263,931,157.’’ 

Dated: March 21, 2022. 

Andi Lipstein Fristedt, 

Deputy Commissioner for Policy, Legislation, 

and International Affairs, U.S. Food and Drug 

Administration. 

[FR Doc. 2022–06427 Filed 3–25–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0336] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Quantitative 

Research on a Voluntary Symbol 

Depicting the Nutrient Content Claim 

‘‘Healthy’’ on Packaged Foods 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing that a proposed collection 

of information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995 

(PRA). 

DATES: Submit written comments 

(including recommendations) on the 

collection of information by April 27, 

2022. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be submitted to https://

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. The title 

of this information collection is 

‘‘Quantitative Research on a Voluntary 

Symbol Depicting the Nutrient Content 

Claim ‘Healthy’ on Packaged Foods.’’ 

Also include the FDA docket number 

found in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: Ila 

S. Mizrachi, Office of Operations, Food 

and Drug Administration, Three White 


jspears on DSK121TN23PROD with NOTICES1